Trademark: 90191284
Word
QUALIGEN THERAPEUTICS
Status Date
Monday, June 12, 2023
Filing Date
Friday, September 18, 2020
Published for Opposition
Tuesday, March 16, 2021
Abandoned Date
Monday, June 12, 2023
10 Medical devices for use in treating or diagnosing cancer; Medical devices for use in treating or diagnosing viral infections
Jun 12, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 12, 2023
Abandonment - No Use Statement Filed
Nov 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 14, 2022
Sou Extension 3 Granted
Nov 14, 2022
Sou Extension 3 Filed
Nov 14, 2022
Sou Teas Extension Received
Jul 22, 2022
Corrected Noa E-Mailed
Jul 21, 2022
Divisional Processing Complete
Jun 22, 2022
Divisional Request Received
Jul 18, 2022
Case Assigned To Intent To Use Paralegal
Jun 22, 2022
Teas Request To Divide Received
Apr 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2022
Sou Extension 2 Granted
Apr 18, 2022
Sou Extension 2 Filed
Apr 18, 2022
Sou Teas Extension Received
Nov 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2021
Sou Extension 1 Granted
Nov 5, 2021
Sou Extension 1 Filed
Nov 5, 2021
Sou Teas Extension Received
May 11, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 16, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 16, 2021
Published For Opposition
Feb 24, 2021
Notification Of Notice Of Publication E-Mailed
Feb 11, 2021
Approved For Pub - Principal Register
Feb 9, 2021
Examiner's Amendment Entered
Feb 9, 2021
Notification Of Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment -Written
Feb 3, 2021
Assigned To Examiner
Oct 27, 2020
New Application Office Supplied Data Entered
Sep 22, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
